BTW, in my experience, BP is almost always wrong about their biotech recommendations. Let's hope their $4.50 is true to form (on the low side).
You might get the full report from: https://www.bellpotter.com.au/ca4/Research/GetFile.aspx?id=0d8948fa-af21-444b-afa2-e1fe7d34823f
If not, maybe some more savvy poster can put it up for you.
Bell Potter downgrade 23 November 2015, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.020(1.83%) |
Mkt cap ! $1.235B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.06 | $2.287M | 2.138M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 14777 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 89130 | 23 |
View Market Depth
| Last trade - 12.35pm 20/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |